Strengthening Patient Safety Through Practical Supplier Quality Oversight | Insights from an Rx‑360 Supplier Quality Working Group Informal Survey

Ensuring patient safety depends on the integrity of global pharmaceutical supply chains—yet Supplier Quality professionals continue to face practical, structural challenges in how audits are conducted, documented, and leveraged for assurance.  

To better understand current practices, Rx‑360 gathered informal responses from members of the Supplier Quality Working Group on the following questions: 

  • How do suppliers respond to audit observations?  
  • Do they add their response to the auditor’s system or send them by email or another method? 
  • Are audits arranged to be conducted, or are existing audit reports from these distributors relied upon?  
  • Alternatively, are there no audit requirements for these sub-suppliers? 

The responses give a clear view into how organizations are managing audit observations and qualifying suppliers in increasingly complex and restricted supply networks. 

Audit Observation Responses: Still Largely Document Driven 

Survey respondents consistently indicated that audit observation responses are managed primarily through document based workflows. Suppliers most often respond via email, typically using formal memos, company letterhead, or templates provided by the auditing organization. These responses are then reviewed and incorporated into the company’s internal electronic Quality Management System (eQMS), either by attaching the original documents or transcribing the content into standardized internal formats. 

While some respondents noted limited experience with system based submission platforms owned by auditors or third parties, direct entry of responses into external systems remains uncommon. Barriers such as licensing costs, access restrictions, interoperability challenges, and varying system standards have slowed adoption. As a result, the prevailing industry model remains one in which documentation is exchanged externally and integrated internally after receipt. 

From a patient safety perspective, this reinforces the need for clear, structured documentation and consistent internal processes—even as digital solutions continue to evolve. 

Qualifying Sub‑Suppliers When Direct Audits Aren’t an Option 

The survey also highlighted a common challenge: restricted access to sub-suppliers, particularly when working through large distributors. In these situations, respondents indicated they rarely audit sub-suppliers directly due to the absence of a contractual relationship. Instead, qualification efforts focus squarely on the direct supplier or distributor. 

The most common assurance strategy is to audit the distributor’s quality system, with particular attention to how the distributor qualifies, monitors, and oversees its own supply chain. This includes evaluating supplier qualification procedures, audit practices, and controls that support material quality and product release. 

To strengthen indirect assurance, organizations often request supporting documentation related to sub‑suppliers, such as: 

  • Existing audit reports 
  • Auditor qualifications and/or CVs 
  • CAPA plans or responses tied to prior findings 

Some respondents also reported sponsoring third-party audits, pursuing direct audits when permissible, or leveraging licensable third‑party audit reports, such as those available through Rx‑360 to close visibility gaps. However, the dominant industry approach remains indirect assurance through robust assessment of the distributor, rather than direct oversight of every entity in the supply chain. 

Practical Insights for Patient Safety 

Taken together, the survey responses underscore a reality familiar to many Supplier Quality professionals: patient safety is often protected not through idealized models of full transparency, but through practical, risk‑based oversight grounded in documentation, governance, and trust frameworks. 

They also reinforce the value of shared audit programs and trusted third‑party resources in addressing access limitations, reducing audit burden, and supporting consistent quality expectations across the industry. 

As supply chains grow more complex, continued collaboration—through forums like Rx‑360’s working groups—remains essential to advancing patient safety while balancing operational realities.